Tobam Sarepta Therapeutics, Inc. Transaction History

Tobam

$548 Million
Q3 2024

A detailed history of Tobam transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Tobam holds 48,890 shares of SRPT stock, worth $5.58 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

48,890

Previous 49,183 0.6%

Holding current value

$5.58 Million

Previous $7.77 Million 21.43%

% of portfolio

1.11%

Previous 1.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$124.33 - $156.75 $36,428 - $45,927	-293 Reduced 0.6%	48,890 $6.11 Million
Q2 2024 Jul 29, 2024	SELL	$113.33 - $163.85 $8.02 Million - $11.6 Million	-70,725 Reduced 58.98%	49,183 $7.77 Million
Q1 2024 May 02, 2024	SELL	$93.7 - $141.53 $3.39 Million - $5.11 Million	-36,138 Reduced 23.16%	119,908 $15.5 Million
Q4 2023 Jan 26, 2024	BUY	$67.31 - $124.76 $478,237 - $886,419	7,105 Added 4.77%	156,046 $15 Million
Q3 2023 Oct 31, 2023	BUY	$102.5 - $123.59 $4.32 Million - $5.21 Million	42,181 Added 39.51%	148,941 $18.1 Million
Q2 2023 Jul 31, 2023	BUY	$106.4 - $157.19 $10 Million - $14.8 Million	94,060 Added 740.63%	106,760 $12.2 Million
Q1 2023 May 03, 2023	BUY	$117.53 - $155.99 $550,157 - $730,189	4,681 Added 58.37%	12,700 $1.75 Million
Q4 2022 Feb 02, 2023	BUY	$100.86 - $132.13 $425,024 - $556,795	4,214 Added 110.75%	8,019 $1.04 Million
Q3 2022 Nov 02, 2022	BUY	$75.71 - $119.24 $288,076 - $453,708	3,805 New	3,805 $421,000
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $25.7 Million - $32.2 Million	-371,107 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$72.25 - $168.95 $21.3 Million - $49.7 Million	294,304 Added 383.19%	371,107 $27.7 Million
Q4 2020 Feb 03, 2021	SELL	$125.56 - $178.74 $3.65 Million - $5.2 Million	-29,083 Reduced 27.47%	76,803 $13.1 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $3.96 Million - $5.36 Million	-31,130 Reduced 22.72%	105,886 $14.9 Million
Q2 2020 Aug 17, 2020	BUY	$93.0 - $171.7 $5.52 Million - $10.2 Million	59,315 Added 76.34%	137,016 $22 Million
Q1 2020 May 07, 2020	BUY	$82.38 - $131.64 $4.61 Million - $7.37 Million	56,012 Added 258.25%	77,701 $7.6 Million
Q4 2019 Feb 10, 2020	BUY	$76.53 - $135.58 $1.62 Million - $2.87 Million	21,193 Added 4272.78%	21,689 $2.8 Million
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $36,113 - $77,827	496 New	496 $37,000
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $27,603 - $37,379	-246 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $10,133 - $14,409	-95 Reduced 27.86%	246 $29,000
Q4 2018 Feb 11, 2019	BUY	$97.32 - $148.76 $33,186 - $50,727	341 New	341 $37,000

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account